Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis

Study Identifier
P12-678
CT.gov Identifier
NCT01387815
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Protocol
Available Language(s): English
Download document(s)
Statistical Analysis Plan
Available Language(s): English
Download document(s)
Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Dermatology - Psoriasis (PsO)
    • Study Drug
  • Adalimumab
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Active moderate or severe plaque psoriasis according to the judgment of the treating physician. * The treating physician has decided to change the current treatment or add additional treatments for any reason including but not limited to inadequate response, intolerance, sub-optimal compliance or participant preference.
    Exclusion Criteria:
    * Had currently participated in another prospective study with similar objectives. * Participant could not or would not sign informed consent. * Presence of other condition that, in the opinion of the treating physician, prohibits the participant from participating in the study or obscured the assessment of the treatment of plaque psoriasis.

    Protocol Summary

    This was a Canadian post-marketing observational study (PMOS) utilizing a prospective cohort design that compared the real - life effectiveness of adalimumab to topical and traditional systemic agents in the management of psoriasis and its impact on the patient's quality of life and societal burden of illness.

    Study Locations

    Location
    Status
    Location
    Kirk Barber Research, CA /ID# 57722
    Calgary, Alberta, Canada, T2G 1B1
    Status
    Not applicable
    Location
    Richmond Road Diagnostic Treat /ID# 70913
    Calgary, Alberta, Canada, T2T 5C7
    Status
    Not applicable
    Location
    Institute for Skin Advancement /ID# 66782
    Calgary, Alberta, Canada, T3A 2N1
    Status
    Not applicable
    Location
    Thomas Nakatsui P.C. /ID# 55080
    Edmonton, Alberta, Canada, T5N 4B2
    Status
    Not applicable
    Location
    Alberta DermaSurgery Centre /ID# 75513
    Edmonton, Alberta, Canada, T6G 1C3
    Status
    Not applicable
    Location
    Wellington Medical Clinic Ltd. /ID# 55083
    Nanaimo, British Columbia, Canada, V9T 1W1
    Status
    Not applicable
    Showing {first} - {last} of {total} Results